Howland Capital Management’s Edwards Lifesciences EW Stock Holding History

Howland Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.81M	Buy	31,092 +3	+0%	+$251	0.1%	106
2026 Q1	$2.49M	Hold	31,089	–	–	0.1%	102
2025 Q4	$2.65M	Hold	31,089	–	–	0.1%	99
2025 Q3	$2.42M	Buy	31,089 +1,153	+4%	+$90.1K	0.09%	103
2025 Q2	$2.34M	Buy	29,936 +816	+3%	+$60.9K	0.1%	104
2025 Q1	$2.11M	Sell	29,120 -67	-0.2%	-$4.79K	0.09%	111
2024 Q4	$2.16M	Buy	29,187 +7	+0%	+$490	0.09%	105
2024 Q3	$1.93M	Hold	29,180	–	–	0.08%	107
2024 Q2	$2.7M	Sell	29,180 -350	-1%	-$31K	0.13%	83
2024 Q1	$2.82M	Hold	29,530	–	–	0.14%	85
2023 Q4	$2.25M	Hold	29,530	–	–	0.12%	96
2023 Q3	$2.05M	Sell	29,530 -80	-0.3%	-$6.43K	0.12%	95
2023 Q2	$2.79M	Hold	29,610	–	–	0.16%	81
2023 Q1	$2.45M	Hold	29,610	–	–	0.15%	83
2022 Q4	$2.21M	Hold	29,610	–	–	0.14%	90
2022 Q3	$2.45M	Buy	29,610 +16,300	+122%	+$1.57M	0.16%	81
2022 Q2	$1.27M	Hold	13,310	–	–	0.08%	105
2022 Q1	$1.57M	Hold	13,310	–	–	0.08%	89
2021 Q4	$1.72M	Buy	13,310 +60	+0.5%	+$7K	0.09%	88
2021 Q3	$1.5M	Sell	13,250 -125	-0.9%	-$14.3K	0.08%	103
2021 Q2	$1.39M	Hold	13,375	–	–	0.07%	104
2021 Q1	$1.12M	Sell	13,375 -842	-6%	-$71.2K	0.06%	114
2020 Q4	$1.3M	Sell	14,217 -199	-1%	-$16.5K	0.08%	101
2020 Q3	$1.15M	Sell	14,416 -3,300	-19%	-$257K	0.08%	100
2020 Q2	$1.22M	Sell	17,716 -1,667	-9%	-$118K	0.09%	97
2020 Q1	$1.22M	Sell	19,383 -2,790	-13%	-$201K	0.11%	97
2019 Q4	$1.72M	Sell	22,173 -360	-2%	-$28.1K	0.12%	90
2019 Q3	$1.65M	Hold	22,533	–	–	0.13%	91
2019 Q2	$1.39M	Hold	22,533	–	–	0.11%	96
2019 Q1	$1.44M	Buy	22,533 +573	+3%	+$32.7K	0.12%	93
2018 Q4	$1.12M	Hold	21,960	–	–	0.11%	101
2018 Q3	$1.27M	Hold	21,960	–	–	0.1%	108
2018 Q2	$1.07M	Hold	21,960	–	–	0.09%	117
2018 Q1	$1.02M	Buy	21,960 +999	+5%	+$43.4K	0.08%	119
2017 Q4	$788K	Hold	20,961	–	–	0.06%	133
2017 Q3	$764K	Hold	20,961	–	–	0.06%	131
2017 Q2	$826K	Hold	20,961	–	–	0.07%	127
2017 Q1	$657K	Buy	20,961 +6,801	+48%	+$213K	0.06%	141
2016 Q4	$442K	Sell	14,160 -6,000	-30%	-$194K	0.04%	151
2016 Q3	$810K	Hold	20,160	–	–	0.08%	121
2016 Q2	$670K	Sell	20,160 -222	-1%	-$7.59K	0.06%	130
2016 Q1	$599K	Buy	20,382 +222	+1%	+$6.13K	0.06%	132
2015 Q4	$531K	Sell	20,160 -9,420	-32%	-$245K	0.05%	145
2015 Q3	$701K	Hold	29,580	–	–	0.08%	127
2015 Q2	$702K	Sell	29,580 -600	-2%	-$13.5K	0.07%	131
2015 Q1	$717K	Hold	30,180	–	–	0.07%	127
2014 Q4	$641K	Sell	30,180 -720	-2%	-$14.5K	0.06%	133
2014 Q3	$526K	Hold	30,900	–	–	0.05%	139
2014 Q2	$442K	Hold	30,900	–	–	0.05%	139
2014 Q1	$382K	Hold	30,900	–	–	0.04%	141
2013 Q4	$339K	Hold	30,900	–	–	0.04%	145
2013 Q3	$359K	Sell	30,900 -1,908,126	-98%	-$22.3M	0.05%	138
2013 Q2	$8.55M	Buy	+1,939,026	New	+$23M	1.35%	30

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Howland Capital Management's EW Position: Q2 2026 in Review

Howland Capital Management increased its Edwards Lifesciences (EW) stake by 0.01% in Q2 2026, buying an estimated $251 and bringing the position to 31,092 shares worth $2.81M. The position accounts for 0.1% of the portfolio, ranked #106.

Howland Capital Management first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.55M in Q2 2013. 265 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Howland Capital Management held 31,092 shares of Edwards Lifesciences worth $2.81M as of Q2 2026.
Howland Capital Management bought 3 Edwards Lifesciences shares in Q2 2026, an estimated $251.
Edwards Lifesciences made up 0.1% of Howland Capital Management's portfolio in Q2 2026, its #106 holding.
Howland Capital Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
Howland Capital Management's Edwards Lifesciences position peaked at $8.55M in Q2 2013.
265 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Howland Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.